A case report involving suppressed nuclear receptor transcription factors 4a1 and stevens-johnson syndrome induced by a single dose of pembrolizumab and successfully treated with early steroid administration, resulting in complete remission of stage iii lung cancer

HIGHLIGHTS

• who: Maiko Machida from the Department of Pharmacotherapy, Faculty of Pharmaceutical Sciences, Hokkaido University of Science, u201115u20114u2011, Maeda Teine, Sapporo, Hokkaido, u20118585, Japan have published the Article: A case report involving suppressed nuclear receptor transcription factors 4a1 and Stevens-Johnson syndrome induced by a single dose of pembrolizumab and successfully treated with early steroid administration, resulting in complete remission of stage III lung cancer, in the Journal: (JOURNAL)
• what: The authors report the case of a patient with a single dose of pembrolizumab-induced Stevens-Johnson syndrome (SJS) successfully treated with steroids, resulting in complete . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.